Suppr超能文献

胃内pH值变化对原位凝胶化果胶制剂的凝胶化及释放特性的影响。

The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations.

作者信息

Itoh Kunihiko, Kubo Wataru, Fujiwara Mariko, Hirayama Tomohiro, Miyazaki Shozo, Dairaku Masatake, Togashi Mitsuo, Mikami Ryozo, Attwood David

机构信息

Faculty of Pharmaceutical Sciences, Health Science University of Hokkaido, Ishikari-Tohbetsu, Hokkaido 061-0293, Japan.

出版信息

Int J Pharm. 2006 Apr 7;312(1-2):37-42. doi: 10.1016/j.ijpharm.2005.12.041. Epub 2006 Feb 13.

Abstract

The aim of this study was to examine the influence of variation of gastric pH over the range 1-3 on the gelation of liquid formulations of pectin and on the in vitro and in vivo release of paracetamol and ambroxol from the resultant gels. The formulations were dilute solutions of pectin containing complexed calcium ions that form gels when these ions are released in the acidic environment of the stomach. Gels suitable as vehicles for sustained delivery of these drugs were formed in vitro at pH<3 from pectin solutions of concentrations 1.0-2.0% (w/v). Very weak gels were formed at pH 3.0 resulting in poor sustained release characteristics compared with those at pH 1.2; no significant in vitro gelation was observed at pH 3.5. The bioavailabilities of paracetamol and ambroxol from gels formed in the stomach following oral administration of the liquid formulations were investigated using gastric-acidity controlled rabbits. Visual observations showed in situ gelation of 1.5% (w/v) pectin formulations under conditions of both high (pH 1.0-1.6) and low gastric acidity (pH 3.3-3.6). The bioavailabilities of these drugs were not significantly different when released from gels formed at the two pH limits suggesting that normal variations of gastric acidity in the fasting state will have no effect on the bioavailability of these drugs when delivered using this vehicle.

摘要

本研究的目的是考察胃内pH值在1 - 3范围内的变化对果胶液体制剂凝胶化以及对扑热息痛和氨溴索从所得凝胶中的体外和体内释放的影响。这些制剂是含有络合钙离子的果胶稀溶液,当这些离子在胃的酸性环境中释放时会形成凝胶。在体外,浓度为1.0 - 2.0%(w/v)的果胶溶液在pH<3时形成了适合作为这些药物缓释载体的凝胶。在pH 3.0时形成的凝胶非常弱,与pH 1.2时形成的凝胶相比,其缓释特性较差;在pH 3.5时未观察到明显的体外凝胶化现象。使用胃酸控制的兔子研究了口服液体制剂后在胃中形成的凝胶中扑热息痛和氨溴索的生物利用度。视觉观察表明,在高胃酸(pH 1.0 - 1.6)和低胃酸(pH 3.3 - 3.6)条件下,1.5%(w/v)果胶制剂会原位凝胶化。当从在两个pH极限形成的凝胶中释放时,这些药物的生物利用度没有显著差异,这表明在禁食状态下胃酸的正常变化对使用该载体给药时这些药物的生物利用度没有影响。

相似文献

1
The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations.
Int J Pharm. 2006 Apr 7;312(1-2):37-42. doi: 10.1016/j.ijpharm.2005.12.041. Epub 2006 Feb 13.
3
In situ gelling pectin formulations for oral drug delivery at high gastric pH.
Int J Pharm. 2007 Apr 20;335(1-2):90-96. doi: 10.1016/j.ijpharm.2006.10.042. Epub 2006 Nov 7.
4
The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol.
Int J Pharm. 2005 Jun 13;297(1-2):38-49. doi: 10.1016/j.ijpharm.2005.02.029. Epub 2005 Apr 25.
6
Oral sustained delivery of ambroxol from in situ-gelling pectin formulations.
Int J Pharm. 2004 Mar 1;271(1-2):233-40. doi: 10.1016/j.ijpharm.2003.11.027.
7
In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery.
Int J Pharm. 2008 May 22;356(1-2):95-101. doi: 10.1016/j.ijpharm.2007.12.049. Epub 2008 Jan 17.
8
In situ gelling pectin formulations for oral sustained delivery of paracetamol.
Drug Dev Ind Pharm. 2004 Jul;30(6):593-9. doi: 10.1081/ddc-120037490.
9
In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Drug Dev Ind Pharm. 2010 Apr;36(4):449-55. doi: 10.3109/03639040903244480.
10
In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients.
Drug Dev Ind Pharm. 2011 Jul;37(7):790-7. doi: 10.3109/03639045.2010.541465. Epub 2011 Mar 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验